Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Existing bitter medicines for fighting 2019‐nCoV‐associated infectious diseases
Xiangqi Li, Chaobao Zhang, Lianyong Liu, et al.
The FASEB Journal (2020) Vol. 34, Iss. 5, pp. 6008-6016
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
Daniel E. Freedberg, Joseph Conigliaro, Timothy C. Wang, et al.
Gastroenterology (2020) Vol. 159, Iss. 3, pp. 1129-1131.e3
Open Access | Times Cited: 253
Causes of hypogeusia/hyposmia in SARS‐CoV2 infected patients
Josef Finsterer, Claudia Stöllberger
Journal of Medical Virology (2020) Vol. 92, Iss. 10, pp. 1793-1794
Open Access | Times Cited: 114
Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6
Wenhao Niu, Feng Wu, Wenyue Cao, et al.
Bioscience Reports (2020) Vol. 41, Iss. 1
Open Access | Times Cited: 95
Histamine receptors and COVID-19
Madeleine Ennis, Ekaterini Tiligada
Inflammation Research (2020) Vol. 70, Iss. 1, pp. 67-75
Open Access | Times Cited: 54
Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugs
Sinosh Skariyachan, Dharshini Gopal, Shweta Chakrabarti, et al.
Computers in Biology and Medicine (2020) Vol. 126, pp. 104054-104054
Open Access | Times Cited: 43
Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID‐19
Wenhao Niu, Feng Wu, Haiming Cui, et al.
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 43
Pharmacological significance of extra-oral taste receptors
Ottavio D'Urso, Filippo Drago
European Journal of Pharmacology (2021) Vol. 910, pp. 174480-174480
Closed Access | Times Cited: 32
20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment
Leon Margolin, Jeremy Luchins, Daniel Margolin, et al.
Journal of Evidence-Based Integrative Medicine (2021) Vol. 26
Open Access | Times Cited: 28
POGZ targeted by LINC01355/miR-27b-3p retards thyroid cancer progression via interplaying with MAD2L2
Jiancan Lu, Xinglu Zhou, Hongling Zhu, et al.
3 Biotech (2025) Vol. 15, Iss. 4
Closed Access
Intranasal Chlorpheniramine for Early Symptomatic Treatment of COVID-19 and the Impact on Long-COVID
Gustavo Ferrer, Fernando Valerio-Pascua, César Alas‐Pineda, et al.
Cureus (2025)
Open Access
Prescription, over-the-counter (OTC), herbal, and other treatments and preventive uses for COVID-19
Jaime A. Yáñez, Sun Ah Chung, Brenda Rojas Román, et al.
Elsevier eBooks (2021), pp. 379-416
Open Access | Times Cited: 22
Biosynthesis, distribution, nutritional and organoleptic properties of bitter compounds in fruit and vegetables
Shengyu Liu, Donald Grierson, Wanpeng Xi
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 7, pp. 1934-1953
Closed Access | Times Cited: 16
Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
Daniel E. Freedberg, Joseph Conigliaro, Magdalena E. Sobieszczyk, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 22
Luteolin is a potential inhibitor of COVID-19: An in silico analysis
Wenxiang Wang, Ce Yang, Jing Xia, et al.
Medicine (2023) Vol. 102, Iss. 38, pp. e35029-e35029
Open Access | Times Cited: 7
Bitter Taste Receptors Expression in Human Granulosa and Cumulus Cells: New Perspectives in Female Fertility
Bianca Semplici, Francesca Paola Luongo, Sofia Passaponti, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3127-3127
Open Access | Times Cited: 17
Upregulation of key factors of viral entry of corona‐ and influenza viruses upon TLR3‐signaling in cells from the respiratory tract and clinical treatment options by 1,8‐Cineol
Leonie Hose, Matthias Schürmann, Holger Sudhoff
Phytotherapy Research (2024) Vol. 38, Iss. 9, pp. 4453-4466
Open Access | Times Cited: 2
TAS2R supports odontoblastic differentiation of human dental pulp stem cells in the inflammatory microenvironment
Wen Kang, Yiwen Wang, Jiaying Li, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Mitigating Coronavirus-Induced Acute Respiratory Distress Syndrome by Radiotherapy
Jian Jian Li
iScience (2020) Vol. 23, Iss. 6, pp. 101215-101215
Open Access | Times Cited: 13
Presence of SARS-CoV-2 and Its Entry Factors in Oral Tissues and Cells: A Systematic Review
Marco Felipe Salas Orozco, Nereyda Niño‐Martínez, Gabriel Alejandro Martínez-Castañón, et al.
Medicina (2021) Vol. 57, Iss. 6, pp. 523-523
Open Access | Times Cited: 11
Intranasal Chlorpheniramine Maleate for the treatment of COVID-19: Translational and Clinical Evidence
Marcos A. Sanchez‐Gonzalez, Jonna B. Westover, Syed A. A. Rizvi, et al.
Medical Research Archives (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 7
In-silico screening of naturally derived phytochemicals against SARS-CoV Main protease
Islam Mostafa, Nashwa H. Mohamed, Basant Mohamed, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 18, pp. 26775-26791
Open Access | Times Cited: 9
Asymptomatic Transmissibility Calls for Implementing a Zero-COVID Strategy to End the Current Global Crisis
Chaobao Zhang, Hongzhi Wang, Zilu Wen, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 6
<p>Blood Targets of Adjuvant Drugs Against COVID19</p>
Pierpaolo Di Micco, Gianluca Di Micco, Vincenzo Russo, et al.
Journal of Blood Medicine (2020) Vol. Volume 11, pp. 237-241
Open Access | Times Cited: 7
Recomendaciones nutricionales para el personal de salud y el personal esencial expuesto a la COVID-19 en Latinoamérica
Cristina Palacios, Jennifer Bernal, Anabelle Bonvecchio, et al.
Archivos Latinoamericanos de Nutrición (2020) Vol. 69, Iss. 4, pp. 242-258
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top